Monday, 09 Dec 2019

You are here

Periodontal Disease and P. gingivalis Increased in CCP+ Pre-Clinical RA

A cross-sectional study 48 CCP–positive "at risk" individuals (without arthritis) were shown to have an increased prevalence of periodontitis and P gingivalis when compared to 26 early RA (ERA) and 32 controls.

anti–cyclic citrullinated protein–positive at-risk individuals (CCP+ at-risk) compared with a healthy control group and patients with early rheumatoid arthritis (RA)? 

CCP+ "at risk" individuals were recruited from a single teaching hospital (2015 to 2017) and underwent periodontal assessments and examination of joints using ultrasonography.

Of the 48 CCP+ at-risk individuals (mean age 51.9 years) 46 had no joint inflammation on ultrasonography, but 35 (73%) had clinical periodontisis. Thus periodontitis in the CCP+ at risk groups was significantly greater than that seen in healthy individuals (38%), and ERA (54%).

The median percentage of periodontal sites was greater in CCP+ at-risk individuals compared with healthy individuals (3.3%). 

Patients with CCP+ at-risk had increased relative abundance of Porphyromonas gingivalis.

Given a substantial rate of progression to RA in asymptomatic, CCP+, no arthritis, "at risk" individuals (as high as 35%), the identification of periodontitis and P gingivalis in such individuals creates an opportunity preventive interventions of RA.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Link Between Obstructive Lung Disease and Developing RA?

We all know that the microbiome in the gut may be very important for multiple immune diseases. However, new findings from the ACR, 2019 in Atlanta reinforce how important the interface is between the lungs and developing rheumatoid arthritis.

Smoking Cessation Lowers RA Disease Activity and CV Risks

A multinational cross-sectional cohort study suggests that smoking cessation in rheumatoid arthritis (RA) patients is associated with lower disease activity measures, improved lipid profiles and lower rates of cardiovascular (CV) events.

Apremilast Reduces Oral Ulcers in Behcet's Syndrome

A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.

Systemic JIA-Associated Lung Disease

A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 

For me, one of most important aspects of attending the ACR Annual Meeting is to learn about conditions that I don’t know and that may afflict my patients when I return back home. This year’s meeting was no different.

Tapering Of Therapy In RA: Maybe Not So Aggressive Next Time

This ACR has seen some more great work on tapering of therapy in rheumatoid arthritis. It’s a hot topic and one which I get asked about all the time by my patients. Commonly when I start oral csDMARDs patients want to know how long they be will on therapy and that naturally leads to a discussion about what the plan will be in the future about tapering.